Case Report
BibTex RIS Cite

Malaria and COVID-19 in an Indigenous Patient, Overlapping of Two Febrile Illnesses

Year 2022, , 27 - 30, 15.03.2022
https://doi.org/10.5799/jmid.1086183

Abstract

ABSTRACT
Coronavirus disease 2019 (COVID-19) is an illness caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Malaria is a parasitic infection caused by the parasite genus Plasmodium. We present the case of a 69-year-old male indigenous patient from Amazonas, Venezuela, who complained of fever, cough, loss of taste and smell, and diarrhea. A SARS-CoV-2 PCR test was positive, and treatment was started. However, over the next few days, his condition worsened. In addition to his previous symptoms, the patient reported profuse sweating accompanied by fever and myalgia. Therefore, a blood smear and ELISA were performed, which were positive for Plasmodium falciparum, for which treatment with antimalarial agents was also started. J Microbiol Infect Dis 2022; 12(1):27-30.

References

  • 1. Di Gennaro F, Marotta C, Locantore P, Pizzol D, Putoto G. Malaria and COVID-19: Common and Different Findings. Trop Med Infect Dis 2020; 5(3):141.
  • 2. Ajayi IO, Ajumobi OO, Falade C. Malaria and COVID-19: commonalities, intersections and implications for sustaining malaria control. Pan Afr Med J 2020; 37 (Suppl 1):1. doi: 10.11604/pamj.supp.2020.37.1.25738.
  • 3. Hassan MI, Dafallah AA, Ahmed O, Homeida A. Malaria and COVID-19: unmasking their ties. Malar J 2020;19:457.
  • 4. Gutman JR, Lucchi NW, Cantey PT, et al. Malaria and Parasitic Neglected Tropical Diseases: Potential Syndemics with COVID-19? Am J Trop Med Hyg 2020;103(2):572-7.
  • 5. Correia MJ, Frade L, Guerreiro R, et al. A Patient with Severe Malaria and COVID-19: How Do You Tell the Difference between These Infections? Eur J Case Rep Intern Med 2020;7(12):002007.
  • 6. Zawawi A, Alsaady I, Gattan H, Zakai H, Couper K. The impact of COVID-19 pandemic on malaria elimination. Paras Epidemiol Control 2020;11;e00187.
  • 7. Rogerson, Beeson J, Laman M, et al. Identifying and combating the impacts of COVID-19 on malaria. BMC Med. 2020;18:239.
  • 8. Gendrot M, Andreani J, Boxberger M, et al. Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation. Travel Med Infect Dis 2020;37:101873.
Year 2022, , 27 - 30, 15.03.2022
https://doi.org/10.5799/jmid.1086183

Abstract

References

  • 1. Di Gennaro F, Marotta C, Locantore P, Pizzol D, Putoto G. Malaria and COVID-19: Common and Different Findings. Trop Med Infect Dis 2020; 5(3):141.
  • 2. Ajayi IO, Ajumobi OO, Falade C. Malaria and COVID-19: commonalities, intersections and implications for sustaining malaria control. Pan Afr Med J 2020; 37 (Suppl 1):1. doi: 10.11604/pamj.supp.2020.37.1.25738.
  • 3. Hassan MI, Dafallah AA, Ahmed O, Homeida A. Malaria and COVID-19: unmasking their ties. Malar J 2020;19:457.
  • 4. Gutman JR, Lucchi NW, Cantey PT, et al. Malaria and Parasitic Neglected Tropical Diseases: Potential Syndemics with COVID-19? Am J Trop Med Hyg 2020;103(2):572-7.
  • 5. Correia MJ, Frade L, Guerreiro R, et al. A Patient with Severe Malaria and COVID-19: How Do You Tell the Difference between These Infections? Eur J Case Rep Intern Med 2020;7(12):002007.
  • 6. Zawawi A, Alsaady I, Gattan H, Zakai H, Couper K. The impact of COVID-19 pandemic on malaria elimination. Paras Epidemiol Control 2020;11;e00187.
  • 7. Rogerson, Beeson J, Laman M, et al. Identifying and combating the impacts of COVID-19 on malaria. BMC Med. 2020;18:239.
  • 8. Gendrot M, Andreani J, Boxberger M, et al. Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation. Travel Med Infect Dis 2020;37:101873.
There are 8 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Case Report
Authors

Isabella Suarez This is me

Rafael Giner This is me

Diana De Oliveira This is me

Marcel Yibirin This is me

Publication Date March 15, 2022
Published in Issue Year 2022

Cite

APA Suarez, I., Giner, R., De Oliveira, D., Yibirin, M. (2022). Malaria and COVID-19 in an Indigenous Patient, Overlapping of Two Febrile Illnesses. Journal of Microbiology and Infectious Diseases, 12(01), 27-30. https://doi.org/10.5799/jmid.1086183
AMA Suarez I, Giner R, De Oliveira D, Yibirin M. Malaria and COVID-19 in an Indigenous Patient, Overlapping of Two Febrile Illnesses. J Microbil Infect Dis. March 2022;12(01):27-30. doi:10.5799/jmid.1086183
Chicago Suarez, Isabella, Rafael Giner, Diana De Oliveira, and Marcel Yibirin. “Malaria and COVID-19 in an Indigenous Patient, Overlapping of Two Febrile Illnesses”. Journal of Microbiology and Infectious Diseases 12, no. 01 (March 2022): 27-30. https://doi.org/10.5799/jmid.1086183.
EndNote Suarez I, Giner R, De Oliveira D, Yibirin M (March 1, 2022) Malaria and COVID-19 in an Indigenous Patient, Overlapping of Two Febrile Illnesses. Journal of Microbiology and Infectious Diseases 12 01 27–30.
IEEE I. Suarez, R. Giner, D. De Oliveira, and M. Yibirin, “Malaria and COVID-19 in an Indigenous Patient, Overlapping of Two Febrile Illnesses”, J Microbil Infect Dis, vol. 12, no. 01, pp. 27–30, 2022, doi: 10.5799/jmid.1086183.
ISNAD Suarez, Isabella et al. “Malaria and COVID-19 in an Indigenous Patient, Overlapping of Two Febrile Illnesses”. Journal of Microbiology and Infectious Diseases 12/01 (March 2022), 27-30. https://doi.org/10.5799/jmid.1086183.
JAMA Suarez I, Giner R, De Oliveira D, Yibirin M. Malaria and COVID-19 in an Indigenous Patient, Overlapping of Two Febrile Illnesses. J Microbil Infect Dis. 2022;12:27–30.
MLA Suarez, Isabella et al. “Malaria and COVID-19 in an Indigenous Patient, Overlapping of Two Febrile Illnesses”. Journal of Microbiology and Infectious Diseases, vol. 12, no. 01, 2022, pp. 27-30, doi:10.5799/jmid.1086183.
Vancouver Suarez I, Giner R, De Oliveira D, Yibirin M. Malaria and COVID-19 in an Indigenous Patient, Overlapping of Two Febrile Illnesses. J Microbil Infect Dis. 2022;12(01):27-30.